Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons.
about
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesParkinson's disease gene therapy: success by design meets failure by efficacyThe candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionGlial cell line-derived neurotrophic factor induces cell proliferation in the mouse urogenital sinus.Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNFNeurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity.Prospects for the treatment of Parkinson's disease using neurotrophic factors.Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusionGDNF-induced seminomatous tumours in mouse--an experimental model for human seminomas?Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2.Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neurons.Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases.Antioxidant and astroprotective effects of a Pulicaria incisa infusion.Targets for neuroprotection in Parkinson's diseaseTrophic factors therapy in Parkinson's disease.Gene therapy for Parkinson's disease: where are we now and where are we going?Mesenchymal cell populations: development of the induction systems for Schwann cells and neuronal cells and finding the unique stem cell population.Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indicationsChallenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.Liver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration.Role of Nectin-1/c-Src Signaling in the Analgesic Effect of GDNF on a Rat Model of Chronic Constrictive Injury.Protective and antioxidant effects of a chalconoid from Pulicaria incisa on brain astrocytes.Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line.Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons.Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET.Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.Glial cell-line derived neurotrophic factor and neurturin regulate the expressions of distinct miRNA precursors through the activation of GFRalpha2.Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones.Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease.Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons.Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival.Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.Nerve growth factor induces P2X(3) expression in sensory neurons.Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture.
P2860
Q26747508-A239A777-C303-47E1-9D3D-8B1BC756B1F3Q26851325-FCFC1F77-22DA-4F19-BFB8-D43B61E4823BQ28591458-08913349-F144-4F6E-A373-48BF13486048Q33631798-B60CD72F-3A45-44E4-8500-558E34E6387CQ33812955-6BCB00B5-9139-4C8F-9D91-61C919B1F5CCQ34108184-232C9D89-5559-4937-9054-DE14FEDE52C6Q34273723-45675F00-F9A1-4E23-872D-B1CC0D8A9FC5Q34515354-B30D937A-550E-4037-A392-9FD9806689F3Q35004270-2EAEA0D2-3E6B-4492-9F6F-86B5EC521881Q35129494-DCCCDBF8-7FC6-4D35-8408-33A4D5EB156FQ35425777-2906437F-BD80-4107-A595-0BD63507BB20Q35671426-1E34F155-DA59-496E-97BE-3EB0C0B49ABAQ36150397-921B9F36-06F3-4EE0-B957-4B222F17D5A7Q36499752-7111EEE3-112F-46E2-B8A3-0A8823847E7BQ36520876-2878352F-39DB-4F82-8AC8-56C744C050D4Q37302453-8A61DDC3-C221-4397-B917-DD4D2096E7C7Q37574424-7D6D8202-BAAE-47DF-ABAC-E318DE666A8CQ37810994-1CB883A4-B115-4443-B898-B8ED2EFBF15AQ37975162-22DF5F95-59E4-4BB6-AC16-4869B9B6B270Q38166648-3F398741-DFD2-49CA-AB73-132EB49500C0Q38194531-217FF925-3B7E-4597-9E82-402B4E733273Q38534041-1DD96093-A029-40D4-BF64-9C6082A897B7Q38759048-206972DC-DB9C-4437-A75C-7779CFAEBEB7Q38992158-8AD81359-DBC6-4AD6-8AA3-0EE765ED4D35Q39486562-E10A6ECF-DFF9-4A8C-8C53-51AD0F282AAAQ39653262-97775539-0041-4338-A8C2-2D77B55C0F6EQ39782948-59124CEE-E3B7-49B8-824F-BC6B6E45DF19Q39826200-864CCEAB-AED1-48DE-9597-63D068117713Q40232814-5CF7E69B-344C-431D-A2F9-67BA1E9F64A6Q40245971-B32C9226-0D31-45E0-9E5F-49C65044C0BBQ40544827-1AEA4F0E-E014-4537-8C30-0330F42A87E8Q40700434-88BFB054-4242-4E88-BF9E-F8ECF63676C0Q40706788-E5EB16A3-C713-42FA-BC2B-074C05CBBDA8Q40724503-C1FEFC96-C1B0-4DF0-9BBD-3B7876CC9DE4Q40737427-17392650-F049-45A6-A525-2035854CF107Q40744948-BB0BCDB5-15F3-4EB5-A65D-A36FF83A0D9BQ40768044-7CB9CF50-EFD3-4214-A537-020EB25F833EQ40777710-29BA5BD2-AF2E-4411-A93E-C45EA210F719Q40809049-55D71ECC-550A-4BFF-9C7D-FE4813F16D3EQ42014526-822D7D1D-C4B4-427E-A3FF-A6F584CBC8CE
P2860
Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Differential effects of glial ...... ia nigra dopaminergic neurons.
@en
type
label
Differential effects of glial ...... ia nigra dopaminergic neurons.
@en
prefLabel
Differential effects of glial ...... ia nigra dopaminergic neurons.
@en
P2093
P2860
P1476
Differential effects of glial ...... ia nigra dopaminergic neurons.
@en
P2093
P2860
P356
10.1046/J.1471-4159.1999.0730070.X
P407
P577
1999-07-01T00:00:00Z